Literature DB >> 21537780

[Campylobacter and campylobacteriosis: a view from South America].

Heriberto Fernández1.   

Abstract

The thermotolerant species of Campylobacter have become very important in public health, especially as agents of infectious diarrhea in human beings. In this brief revision we present part of the available information generated in South America about epidemiological, clinical and bacteriological aspects of campylobacteriosis and we identify some differences between the observed and documented campylobacteriosis in South America compared to those described in industrialized countries.

Entities:  

Mesh:

Year:  2011        PMID: 21537780     DOI: 10.1590/s1726-46342011000100019

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  11 in total

1.  Serological Markers of Recent Campylobacter jejuni Infection in Patients with Guillain-Barré Syndrome in the State of Piauí, Brazil, 2014-2016.

Authors:  Cintya O Souza; Marcelo A C S Vieira; Francisca M A Batista; Kelsen D Eulálio; Jéssica M M Neves; Laís C Sá; Leni C R Monteiro; Walfrido S Almeida-Neto; Raimunda S S Azevedo; Dorcas L Costa; Ana C R Cruz
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  Identifying etiological agents causing diarrhea in low income Ecuadorian communities.

Authors:  Gabriela Vasco; Gabriel Trueba; Richard Atherton; Manuel Calvopiña; William Cevallos; Thamara Andrade; Martha Eguiguren; Joseph N S Eisenberg
Journal:  Am J Trop Med Hyg       Date:  2014-07-21       Impact factor: 2.345

4.  ISOLATION AND MOLECULAR IDENTIFICATION OF POTENTIALLY PATHOGENIC Escherichia coli AND Campylobacter jejuni IN FERAL PIGEONS FROM AN URBAN AREA IN THE CITY OF LIMA, PERU.

Authors:  Moisés Caballero; Isabel Rivera; Luis M Jara; Francisco M Ulloa-Stanojlovic; Carlos Shiva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

5.  Campylobacter antimicrobial resistance in Peru: a ten-year observational study.

Authors:  Simon Pollett; Claudio Rocha; Rito Zerpa; Lilian Patiño; Augusto Valencia; Máximo Camiña; José Guevara; Martha Lopez; Nancy Chuquiray; Eduardo Salazar-Lindo; Carlos Calampa; Martín Casapia; Rina Meza; Maruja Bernal; Drake Tilley; Michael Gregory; Ryan Maves; Eric Hall; Franca Jones; C Sofia Arriola; Marieke Rosenbaum; Juan Perez; Matthew Kasper
Journal:  BMC Infect Dis       Date:  2012-08-16       Impact factor: 3.090

6.  Impact of changing from staining to culture techniques on detection rates of Campylobacter spp. in routine stool samples in Chile.

Authors:  Lorena Porte; Carmen Varela; Thomas Haecker; Sara Morales; Thomas Weitzel
Journal:  BMC Infect Dis       Date:  2016-05-13       Impact factor: 3.090

7.  Occurrence and antimicrobial susceptibility of thermophilic Campylobacter species isolated from healthy children attending municipal care centers in Southern Ecuador.

Authors:  Zorayda Toledo; Rosa Janneth Simaluiza; Xavier Astudillo; Heriberto Fernández
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-12-21       Impact factor: 1.846

8.  Campylobacter jejuni bacteremia in a patient with asplenia and enteritis.

Authors:  Ramírez Isabel
Journal:  IDCases       Date:  2019-05-09

9.  Genomic analysis of the diversity, antimicrobial resistance and virulence potential of clinical Campylobacter jejuni and Campylobacter coli strains from Chile.

Authors:  Veronica Bravo; Assaf Katz; Lorena Porte; Thomas Weitzel; Carmen Varela; Narjol Gonzalez-Escalona; Carlos J Blondel
Journal:  PLoS Negl Trop Dis       Date:  2021-02-19

10.  Arcobacter butzleri and A. cryaerophilus in human, animals and food sources, in southern Chile.

Authors:  Heriberto Fernandez; Maria Paz Villanueva; Ingrid Mansilla; Mario Gonzalez; Fadua Latif
Journal:  Braz J Microbiol       Date:  2015-03-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.